Sort
82,697 grants matching “vaccine development”
Task 12 (D19) Testing of Antibiotics Against Inhalational Melioidosis and Glander
$4,757,562Uk Health Security Agency · N01 · FY2009 · AI
Radiation Oncology Branch - Radiation Clinic
$4,754,853Kevin Camphausen · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
UCSD Department of Medicine HIV/AIDS Clinical Trials Unit
$4,754,262Constance Ann Benson · University Of California, San Diego · U01 · FY2010 · AI
HIV VACCINE TRIALS NETWORK LEADERSHIP GROUP
$4,753,232Fred Hutchinson Cancer Research Center · U01 · FY2001 · AI
Leadership for HIV/AIDS Clinical Trials Networks; HIV Prevention Trials Network
$4,752,947Deborah J Donnell · Fred Hutchinson Cancer Research Center · U01 · FY2010 · AI
CORE NICHD NETWORK CLINICAL SITE SUPPORT FOR IMPAACT RELATED STUDIES
$4,748,065Barbara Driver · Westat, Inc. · N01 · FY2025 · HD
Global Identification of Dengue Virus Epitopes Following Exposure, Vaccination, and Acute Infection
$4,745,745Maya Mitchell · La Jolla Institute For Immunology · N01 · FY2014 · AI
Regional Biocontainment Laboratory (RBL) for Region V
$4,740,444University Of Chicago · UC6 · FY2005 · AI
Characterizing pediatric genomes through an optimized sequencing approach
$4,737,578Shawn E Levy · Hudson-Alpha Institute For Biotechnology · U24 · FY2017 · HD
Core A: Administrative Core
$4,737,502Sean P. J. Whelan · Washington University · U19 · FY2024 · AI
GM-CSF-Adjuvanted Clade C DNA/MVA and MVA/MVA Vaccines
$4,736,301Harriet L Robinson · Geovax, Inc. · U19 · FY2009 · AI
Soweto Clinical Trials Unit
$4,732,001Glenda Gray · Wits Health Consortium (Pty), Ltd · U01 · FY2011 · AI
Epigenomic analysis of primary immune cells from young and old animals
$4,731,289Myong-Hee Sung · National Institute On Aging · ZIA · FY2020 · AG
MALARIA VACCINE PRODUCTION AND SUPPORT SERVICES
$4,730,568Kathleen Kootz · Science Applications International Corp · N01 · FY2012 · AI
Project 1: Vaccine Design Neurotropic Flaviviruses
$4,728,047Aaron Gregory Schmidt · Washington University · U19 · FY2024 · AI
PREMISE: Pandemic Response Repository through Microbial and Immune Surveillance and Epidemiology
$4,728,022Daniel Cesar Douek · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
CIPRA-SA: Safeguard the household: comprehensive AIDS research: Extension
$4,725,422James Alasdair McIntyre · Wits Health Consortium (Pty), Ltd · U19 · FY2009 · AI
Development of a Long-acting Enzyme Therapy for Treatment of Cocaine Abuse
$4,721,164Chang-Guo Zhan · University Of Kentucky · U01 · FY2022 · DA
Conjugate nanoparticle platform development for HIV-1 envelope immunogens
$4,719,580Kevin O Saunders · Duke University · U19 · FY2022 · AI
NIAID Centers of Excellence for Influenza Research and Response: Universal Influenza Vaccine Research Activities
$4,713,497Scott Hensley · University Of Pennsylvania · N01 · FY2024 · AI
Adaptive and Innate Immunity, Memory and Repertoire in Vaccination and Infection
$4,710,430Mark M Davis · Stanford University · U19 · FY2018 · AI
Small molecule stimulators of innate immune receptors
$4,707,516Dennis A Carson · University Of California, San Diego · N01 · FY2009 · AI
UZ-UCSF CTU
$4,705,169Zvavahera Mike Chirenje · University Of California, San Francisco · UM1 · FY2023 · AI
SURGERY IMMUNOLOGY AND IMMUNOTHERAPY OF HUMAN CANCER
$4,704,543John Wayne Cancer Institute · P01 · FY2001 · CA
LEADERSHIP GROUP FOR ADOLESCENT MEDICINE TRIALS NETWORK
$4,704,138University Of Alabama At Birmingham · U01 · FY2005 · HD